Additionally, WB experiments demonstrated that ART significantly reduced the expression of G1 phase markers CDK2 and CDK4 while increasing p53 expression, suggesting that ART promoted BLCA cell cycle arrest by activating the p53 pathway. The gene discussed is CDK4; the disease is bladder transitional cell carcinoma.